HERBAL REMEDY OF THE MONTH
Atrosan Devil’s Claw tablets has been awarded a Traditional
Herbal Medicines Directive licence for the relief of backache,
rheumatic or muscular pain, and general aches and pains in the
muscles and joints. It's the equivalent of the clinical licence
for a pharmaceutical drug - and gives a solid guarantee that the
supplement is effective.
Devil’s Claw or Harpagophytum is valued for its
anti-inflammatory properties, which make it a popular and
effective herbal remedy for problems such as rheumatism,
backache and sports injuries. Devil’s Claw has
anti-inflammatory, anti-rheumatic and analgesic properties, due
to a group of components called iridoids, the principle of which
is harpagoside. Its anti-inflammatory activity is equivalent to
corticosteroids but without the potential side effects. Devil’s
Claw reduces pain and inflammation and is safe for long term
A clinical trial to investigate the effects of Harpagophytum
tablets for the treatment of general rheumatic disorders had
encouraging results. Pain and stiffness improved significantly.
70% of patients reported a beneficial effect from using the
tablets and 78% said they would take them again. 92% rated
tolerability of Devil’s Claw as good.
The supplements are also green: an example of Bioforce’s
commitment to sustainable cultivation. The increasing popularity
of Devil’s Claw threatens the plant with extinction and also the
livelihood of the South African indigenous people who harvest
it. Every year, up to 15 million wild Devil’s Claw plants are
uprooted in the Kalahari to meet demand. The herb is very
difficult to cultivate but Bioforce has worked for several years
with international scientists and local producers to develop a
unique sustainable Devil’s Claw crop. The specially created farm
is also making a positive contribution to the local economy.
A.Vogel Atrosan Devil’s Claw tablets are specially coated to
protect the active ingredients from stomach enzymes. The newly
packaged tablets cost ?8.95 (30) and ?15.95 (60) and will be
available from 14 April in health stores.